OrbiMed’s Elevance Health ELV Stock Holding History

OrbiMed’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.87M	Buy	+10,000	New	+$3.71M	0.07%	110

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OrbiMed's ELV Position: Q2 2026 in Review

OrbiMed held its Elevance Health (ELV) position steady in Q2 2026 at 114,700 shares worth $44.4M. The position accounts for 0.82% of the portfolio, ranked #40.

OrbiMed first reported a position in ELV in Q2 2013 and has held it in 29 quarters since. The position peaked at $176M in Q3 2017. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

OrbiMed held 114,700 shares of Elevance Health worth $44.4M as of Q2 2026.
OrbiMed left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.82% of OrbiMed's portfolio in Q2 2026, its #40 holding.
OrbiMed first reported a position in Elevance Health in Q2 2013 and has held it in 29 quarters since.
OrbiMed's Elevance Health position peaked at $176M in Q3 2017.
1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.